This metabolite has a PDE selectivity profile similar to sildenafil and an in vitro potency for PDE5 roughly 50% from the father or mother drug. Plasma concentrations of this metabolite are about 40% of All those seen for sildenafil, so that the metabolite accounts for about twenty% of sildenafil's pharmacologic consequences.For those who have spec